What would 200% US tariffs on generic drugs mean for China’s pharmaceutical industry?
Despite Washington’s move to tighten policy on pharmaceutical trade with a fresh threat of 100 per cent tariffs on generic drug imports, analysts say China’s pharmaceutical rise is now tariff-proof, making its ascent in the global supply chain look irreversible. US President Donald Trump announced plans on Tuesday to impose escalating tariffs on all generic drugs shipped to the country beginning in August 2028. Under the proposed schedule, tariffs would rise to 100 per cent within the first year...
Read the full story at Business - South China Morning Post →